Angiotensin I-converting enzyme activity and vascular sensitivity to angiotensin I in rat injured carotid artery

Eur J Pharmacol. 2000 Apr 14;394(2-3):301-9. doi: 10.1016/s0014-2999(00)00071-6.

Abstract

We used a vasoreactivity assay to examine the functional significance of angiotensin I-converting enzyme overexpression in smooth muscle cells after vascular injury. Rat carotid arteries isolated at days 2 to 14 after in vivo endothelial denudation were compared with the contralateral freshly denuded (control) vessels. Arterial rings were constricted ex vivo with angiotensin I in the absence or presence of the angiotensin I-converting enzyme inhibitors captopril (300 nM and 3 microM) or perindoprilate (1 nM). Angiotensin I-converting enzyme activity was determined by cleavage of the chromogenic substrate Hip-His-Leu. Angiotensin I-converting enzyme activity in injured arteries was increased (2-fold) at day 7 only after vascular injury. Contractions to angiotensin I were unaffected after injury. Inhibition by captopril and perindoprilate of angiotensin I-induced contractions was significantly less potent in injured arteries at day 7 as compared to control vessels. Mechanical removal of neointimal smooth muscle cells normalized the inhibition by captopril in injured arteries at day 7. Captopril did not affect angiotensin II-induced contractions. Thus, upregulation of angiotensin I-converting enzyme after arterial injury confers resistance to angiotensin I-converting enzyme inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioplasty, Balloon
  • Angiotensin I / pharmacology*
  • Animals
  • Carotid Artery Injuries / drug therapy*
  • Carotid Artery Injuries / pathology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiology
  • Male
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects*
  • Peptidyl-Dipeptidase A / metabolism*
  • Phenylephrine / pharmacology
  • Potassium Chloride / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors
  • Up-Regulation / drug effects
  • Vasoconstrictor Agents / pharmacology

Substances

  • Vasoconstrictor Agents
  • Phenylephrine
  • Potassium Chloride
  • Angiotensin I
  • Peptidyl-Dipeptidase A